Structural basis for the inhibition of the eukaryotic ribosome
暂无分享,去创建一个
Marina V. Rodnina | M. Rodnina | M. Yusupov | G. Yusupova | N. G. D. Loubresse | Gulnara Yusupova | Marat Yusupov | Wolf Holtkamp | Nicolas Garreau de Loubresse | Irina Prokhorova | I. Prokhorova | W. Holtkamp
[1] V. G. Panse,et al. A new system for naming ribosomal proteins. , 2014, Current opinion in structural biology.
[2] Shaoguang Li,et al. Omacetaxine mepesuccinate in the treatment of intractable chronic myeloid leukemia , 2014, OncoTargets and therapy.
[3] H. Boukari,et al. 4′-O-substitutions determine selectivity of aminoglycoside antibiotics , 2014, Nature Communications.
[4] Daniel N. Wilson. Ribosome-targeting antibiotics and mechanisms of bacterial resistance , 2013, Nature Reviews Microbiology.
[5] J. Schacht,et al. Designer Aminoglycosides That Selectively Inhibit Cytoplasmic Rather than Mitochondrial Ribosomes Show Decreased Ototoxicity , 2013, The Journal of Biological Chemistry.
[6] Aravind Subramanian,et al. Tight Coordination of Protein Translation and HSF1 Activation Supports the Anabolic Malignant State , 2013, Science.
[7] A. Korostelev,et al. Blasticidin S inhibits translation by trapping deformed tRNA on the ribosome , 2013, Proceedings of the National Academy of Sciences.
[8] J. Darnell,et al. The translation of translational control by FMRP: therapeutic targets for FXS , 2013, Nature Neuroscience.
[9] M. Cooper,et al. Aminoglycoside antibiotics in the 21st century. , 2013, ACS chemical biology.
[10] T. Steitz,et al. Elements of ribosomal drug resistance and specificity. , 2012, Current opinion in structural biology.
[11] M. Yusupov,et al. Crystal structure of the 80S yeast ribosome. , 2012, Current opinion in structural biology.
[12] O. Namy,et al. Sense from nonsense: therapies for premature stop codon diseases. , 2012, Trends in molecular medicine.
[13] B. Shen,et al. Global mapping of translation initiation sites in mammalian cells at single-nucleotide resolution , 2012, Proceedings of the National Academy of Sciences.
[14] M. Yusupov,et al. One core, two shells: bacterial and eukaryotic ribosomes , 2012, Nature Structural &Molecular Biology.
[15] E. Westhof,et al. A new understanding of the decoding principle on the ribosome , 2012, Nature.
[16] Meitian Wang,et al. Optimal fine ϕ-slicing for single-photon-counting pixel detectors , 2011, Acta crystallographica. Section D, Biological crystallography.
[17] Sergey Melnikov,et al. The Structure of the Eukaryotic Ribosome at 3.0 Å Resolution , 2011, Science.
[18] N. Ban,et al. Crystal Structure of the Eukaryotic 60S Ribosomal Subunit in Complex with Initiation Factor 6 , 2011, Science.
[19] Nicholas T. Ingolia,et al. Ribosome Profiling of Mouse Embryonic Stem Cells Reveals the Complexity and Dynamics of Mammalian Proteomes , 2011, Cell.
[20] Marcus Mueller,et al. Optimal fine ϕ slicing for single photon counting pixel detectors , 2011 .
[21] N. A. Stover,et al. Trichothecenes: From Simple to Complex Mycotoxins , 2011, Toxins.
[22] S. Hobbie,et al. Genetic Reconstruction of Protozoan rRNA Decoding Sites Provides a Rationale for Paromomycin Activity against Leishmania and Trypanosoma , 2011, PLoS Neglected Tropical Diseases.
[23] T. Mahmud,et al. Biosynthetic studies and genetic engineering of pactamycin analogs with improved selectivity toward malarial parasites. , 2011, Chemistry & biology.
[24] J. Nakayama,et al. Methylation of Ribosomal Protein L42 Regulates Ribosomal Function and Stress-adapted Cell Growth* , 2010, The Journal of Biological Chemistry.
[25] P. Emsley,et al. Features and development of Coot , 2010, Acta crystallographica. Section D, Biological crystallography.
[26] Tilman Schneider-Poetsch,et al. Inhibition of Eukaryotic Translation Elongation by Cycloheximide and Lactimidomycin , 2010, Nature chemical biology.
[27] Randy J. Read,et al. Acta Crystallographica Section D Biological , 2003 .
[28] T. Steitz,et al. Structures of Triacetyloleandomycin and Mycalamide A Bind to the Large Ribosomal Subunit of Haloarcula marismortui , 2009, Antimicrobial Agents and Chemotherapy.
[29] T. Steitz,et al. U2504 determines the species specificity of the A-site cleft antibiotics: the structures of tiamulin, homoharringtonine, and bruceantin bound to the ribosome. , 2009, Journal of molecular biology.
[30] Nicholas T. Ingolia,et al. Genome-Wide Analysis in Vivo of Translation with Nucleotide Resolution Using Ribosome Profiling , 2009, Science.
[31] S. Van slambrouck,et al. Biological Evaluation of Structurally Diverse Amaryllidaceae Alkaloids and their Synthetic Derivatives: Discovery of Novel Leads for Anticancer Drug Design , 2009, Planta medica.
[32] A. Hinnebusch,et al. Regulation of Translation Initiation in Eukaryotes: Mechanisms and Biological Targets , 2009, Cell.
[33] G. Adam,et al. Molecular mechanisms of deoxynivalenol resistance in the yeastSaccharomyces cerevisiae , 2001, Mycotoxin Research.
[34] E. Duffy,et al. Design at the atomic level: generation of novel hybrid biaryloxazolidinones as promising new antibiotics. , 2008, Bioorganic & medicinal chemistry letters.
[35] Hua Fan-Minogue,et al. Eukaryotic ribosomal RNA determinants of aminoglycoside resistance and their role in translational fidelity. , 2007, RNA.
[36] Yanli Wang,et al. PubChem: Integrated Platform of Small Molecules and Biological Activities , 2008 .
[37] Jie Luo,et al. Retrieval of Crystallographically-Derived Molecular Geometry Information , 2004, J. Chem. Inf. Model..
[38] J. Pelletier,et al. Eukaryotic protein synthesis inhibitors identified by comparison of cytotoxicity profiles. , 2004, RNA.
[39] Daniel N. Wilson,et al. Dissecting the ribosomal inhibition mechanisms of edeine and pactamycin: the universally conserved residues G693 and C795 regulate P-site RNA binding. , 2004, Molecular cell.
[40] K. Schappert,et al. Isolation and characterization of Saccharomyces cerevisiae mutants resistant to T-2 toxin , 1988, Current Genetics.
[41] A. Jiménez,et al. Genetics and biochemistry of cryptopleurine resistance in the yeast Saccharomyces cerevisiae , 1977, Molecular and General Genetics MGG.
[42] Thomas A Steitz,et al. Structures of five antibiotics bound at the peptidyl transferase center of the large ribosomal subunit. , 2003, Journal of molecular biology.
[43] V. Ramakrishnan,et al. Selection of tRNA by the Ribosome Requires a Transition from an Open to a Closed Form , 2002, Cell.
[44] Wayne A. Decatur,et al. rRNA modifications and ribosome function. , 2002, Trends in biochemical sciences.
[45] Nan Yu,et al. The Comparative RNA Web (CRW) Site: an online database of comparative sequence and structure information for ribosomal, intron, and other RNAs , 2002, BMC Bioinformatics.
[46] A Yonath,et al. Crystal structures of complexes of the small ribosomal subunit with tetracycline, edeine and IF3 , 2001, The EMBO journal.
[47] V. Ramakrishnan,et al. The Structural Basis for the Action of the Antibiotics Tetracycline, Pactamycin, and Hygromycin B on the 30S Ribosomal Subunit , 2000, Cell.
[48] D. Bedwell,et al. Aminoglycoside antibiotics mediate context-dependent suppression of termination codons in a mammalian translation system. , 2000, RNA.
[49] J. Puglisi,et al. Basis for prokaryotic specificity of action of aminoglycoside antibiotics , 1999, The EMBO journal.
[50] P. Lefebvre,et al. The CRY1 gene in Chlamydomonas reinhardtii: structure and use as a dominant selectable marker for nuclear transformation , 1994, Molecular and cellular biology.
[51] A. Paulovich,et al. Molecular genetics of cryptopleurine resistance in Saccharomyces cerevisiae: expression of a ribosomal protein gene family. , 1993, Genetics.
[52] J. Davies,et al. Natural cycloheximide resistance in yeast. The role of ribosomal protein L41. , 1993, European journal of biochemistry.
[53] S. Kawai,et al. Drastic alteration of cycloheximide sensitivity by substitution of one amino acid in the L41 ribosomal protein of yeasts , 1992, Journal of bacteriology.
[54] G. Karpova,et al. Alkaloid homoharringtonine inhibits polypeptide chain elongation on human ribosomes on the step of peptide bond formation , 1989, FEBS letters.
[55] J. Middlebrook,et al. Binding of T-2 toxin to eukaryotic cell ribosomes. , 1989, Biochemical pharmacology.
[56] K. Ehrlich,et al. Protein synthesis inhibition by 8-oxo-12,13-epoxytrichothecenes. , 1987, Biochimica et biophysica acta.
[57] W. Wintermeyer,et al. Affinities of tRNA binding sites of ribosomes from Escherichia coli. , 1986, Biochemistry.
[58] J. Wilhelm,et al. Mechanisms of action of aminoglycoside antibiotics in eucaryotic protein synthesis , 1984, Antimicrobial Agents and Chemotherapy.
[59] M. Kukhanova,et al. Peptidyltransferase center of ribosomes , 1983, FEBS letters.
[60] J. Friesen,et al. Nucleotide sequence of the tcml gene (ribosomal protein L3) of Saccharomyces cerevisiae , 1983, Journal of bacteriology.
[61] J. Warner,et al. Cycloheximide resistance in yeast: the gene and its protein. , 1983, Nucleic acids research.
[62] A. Jimenez,et al. Quantitation of the specific interaction of [14a-3H]cryptopleurine with 80S and 40S ribosomal species from the yeast Saccharomyces cerevisiae. , 1982, Biochemistry.
[63] E. Cundliffe,et al. Ribosomal resistance to the 12,13-epoxytrichothecene antibiotics in the producing organism Myrothecium verrucaria. , 1980, The Biochemical journal.
[64] W. Wintermeyer,et al. Fluorescent derivatives of yeast tRNAPhe. , 1979, European journal of biochemistry.
[65] D. Vazquez. Inhibitors of Protein Biosynthesis , 1979, Molecular Biology Biochemistry and Biophysics.
[66] A. Shatkin,et al. Migration of 40 S ribosomal subunits on messenger RNA in the presence of edeine. , 1978, The Journal of biological chemistry.
[67] Luis Carrasco,et al. Inhibition, by selected antibiotics, of protein synthesis in cells growing in tissue cultures. , 1978, The Journal of antibiotics.
[68] D. Vazquez,et al. Binding of [3H]narciclasine to eukaryotic ribosomes. A study on a structure-activity relationship. , 1978, Biochimica et biophysica acta.
[69] M. Fresno,et al. Inhibition of translation in eukaryotic systems by harringtonine. , 1977, European journal of biochemistry.
[70] K. Bucher,et al. Cryptopleurine--an inhibitor of translocation. , 1976, Biochemistry.
[71] A. Santos,et al. Inhibitors of protein synthesis in eukarytic cells. Comparative effects of some amaryllidaceae alkaloids. , 1976, Biochimica et biophysica acta.
[72] A. Jimenez,et al. Location of resistance to the alkaloid narciclasine in the 60S ribosomal subunit , 1975, FEBS letters.
[73] A. Jimenez,et al. Simultaneous ribosomal resistance to trichodermin and anisomycin in Saccharomyces cerevisiae mutants. , 1975, Biochimica et biophysica acta.
[74] Luis Carrasco,et al. Narciclasine: an antitumour alkaloid which blocks peptide bond formation by eukaryotic ribosomes , 1975, FEBS letters.
[75] J. Davies,et al. Mechanism of inhibition of eukaryotic protein synthesis by trichothecene fungal toxins. , 1974, Proceedings of the National Academy of Sciences of the United States of America.
[76] A. Grollman. Inhibitors of protein biosynthesis. II. Mode of action of anisomycin. , 1967, The Journal of biological chemistry.
[77] H. Yamaguchi,et al. Inhibition of protein synthesis by blasticidin S. II. Studies on the site of action in E. coli polypeptide synthesizing systems. , 1966, Journal of biochemistry.
[78] H. Yamaguchi,et al. Inhibition of protein synthesis by blasticidin S. I. Studies with cell-free systems from bacterial and mammalian cells. , 1965, Journal of biochemistry.